Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DNC007258

Drug Information
IndicationNot AvailableExperimental    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1(=C(C2=NNN=C2C(=C1Br)Br)Br)Br    
TargetAMP-activated protein kinase, beta-1 subunitInhibitor[1]
Casein kinase II alphaInhibitor[2]
Dual specificity mitogen-activated protein kinase kinase 1Inhibitor[1]
Glycogen synthase kinase-3 betaInhibitor[1]
MAP kinase ERK2Inhibitor[1]
MAP kinase p38 alphaInhibitor[1]
MAP kinase p38 betaInhibitor[1]
MAP kinase p38 gammaInhibitor[1]
Protein kinase C alpha Inhibitor[1]
Rho-associated protein kinase 2Inhibitor[1]
Ribosomal protein S6 kinase alpha 5Inhibitor[1]
Serine/threonine-protein kinase AKTInhibitor[1]
Serine/threonine-protein kinase Chk1 Inhibitor[1]
Serine/threonine-protein kinase Sgk1Inhibitor[1]
Tyrosine-protein kinase LCKInhibitor[1]
c-Jun N-terminal kinase 1Inhibitor[1]
Ref 1J Med Chem. 2004 Dec 2;47(25):6239-47.Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole. To Reference
Ref 2Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3. Epub 2009 Apr 22.Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543